MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
6.38
+0.06
+0.95%
After Hours: 6.38 0 0.00% 16:10 07/07 EDT
OPEN
6.41
PREV CLOSE
6.32
HIGH
6.47
LOW
6.10
VOLUME
2.24M
TURNOVER
--
52 WEEK HIGH
21.73
52 WEEK LOW
5.02
MARKET CAP
1.23B
P/E (TTM)
-6.0526
1D
5D
1M
3M
1Y
5Y
1D
Wave Life Sciences sets July 14 Singapore court hearing for US redomiciliation scheme approval
PUBT · 2h ago
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
Barchart · 7h ago
Weekly Report: what happened at WVE last week (0629-0703)?
Weekly Report · 1d ago
Weekly Report: what happened at WVE last week (0622-0626)?
Weekly Report · 06/29 09:13
Wave Life Sciences Shareholders Approve Redomiciliation Scheme
TipRanks · 06/26 12:59
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
Seeking Alpha · 06/26 12:40
Wave Life Sciences holds shareholder meeting on redomiciliation scheme proposal
PUBT · 06/26 12:34
Wave Life Sciences Starts Phase 2a INLIGHT Trial Of WVE-007 In Obesity And Metabolic Disease
NASDAQ · 06/25 07:26
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, as well as several preclinical programs utilizing the Company's broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.